세계
보수 성향
Trump’s 200% tariffs on pharma: Why India’s generic medicines could still remain competitive
The Times of India
US President Donald Trump on Tuesday announced the final stage of his pharmaceutical tariff plan, under which imported generic medicines will continue to enter the US without duties until August 1, 2028. ...
이 뉴스, 어떠셨어요?
탭 한 번으로 반응 · 로그인 불필요
관련 뉴스
39건 · 26개 매체진보 성향 16%중도 성향 44%보수 성향 40%
4개 매체11개 매체10개 매체
관련 뉴스 제보는 로그인 후 가능합니다.
'world' 카테고리 뉴스
The Times of India의 다른 기사
BPCL posts Rs 3,962 crore Q1 loss as high crude prices squeeze fuel margins
The Times of India
Delhi ACP injured in fresh stone-pelting near Tolstoy Marg as CJP protest continues at Jantar Mantar
The Times of India
'Used to getting punched': Rahul says he's 'ready to take many more' after detention
The Times of India